GRFS
Grifols SA ADR
NASDAQ: GRFS · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$7.91
-1.98% today
Updated 2026-04-29
Market cap
$5.38B
P/E ratio
11.46
P/S ratio
0.72x
EPS (TTM)
$0.69
Dividend yield
2.22%
52W range
$7 – $11
Volume
0.8M
WallStSmart proprietary scores
71
out of 100
Grade: B
Buy
Investment rating
6.7
Growth
B5.0
Quality
C+5.5
Profitability
C+10.0
Valuation
A+3/9
Piotroski F-Score
Weak
1.1
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$11.10
+40.33%
12-Month target
$9.35
+18.20%
Intrinsic (DCF)
$19.42
Margin of safety
+52.57%
0 Strong Buy1 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $335.21M — positive
+ 52.57% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 1.13 — distress zone
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $6.06B | $6.59B | $7.21B | $7.23B | $7.52B |
| Net income | $185.03M | $42.32M | $156.92M | $386.13M | $97.33M |
| EPS | — | — | — | — | $0.69 |
| Free cash flow | $-386.43M | $-91.63M | $530.80M | $751.14M | $335.21M |
| Profit margin | 3.05% | 0.64% | 2.18% | 5.34% | 5.34% |
Peer comparison
Smart narrative
Grifols SA ADR trades at $7.91. representing a P/E of 11.46x trailing earnings. Our Smart Value Score of 71/100 indicates the stock is good. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 1.13, it sits in the distress. TTM revenue stands at $7.52B. with profit margins at 5.34%. Our DCF model estimates intrinsic value at $19.42.
Frequently asked questions
What is Grifols SA ADR's stock price?
Grifols SA ADR (GRFS) trades at $7.91.
Is Grifols SA ADR overvalued?
Smart Value Score 71/100 (Grade B, Buy). DCF value $19.42.
What is the price target of Grifols SA ADR (GRFS)?
The analyst target price is $11.10, representing +40.3% upside from the current price of $7.91.
What is the intrinsic value of Grifols SA ADR (GRFS)?
Based on our DCF model, intrinsic value is $19.42, a +52.6% margin of safety versus $7.91.
What is Grifols SA ADR's revenue?
TTM revenue is $7.52B.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
1.13 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - GENERAL
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.72x
ROE6.17%
Beta1.21
50D MA$8.34
200D MA$9.21
Shares out0.68B
Float0.42B
Short ratio—
Avg volume0.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—